Glyoxylic Acid
Product Description
Changzhou Comwin Fine Chemicals Co., Ltd
-
CN
-
2015On CPHI since
Company types
Specifications
Changzhou Comwin Fine Chemicals Co., Ltd
-
CN
-
2015On CPHI since
Company types
More Products from Changzhou Comwin Fine Chemicals Co., Ltd (99)
-
Product Flumequine Sodium
CAS:108612-45-9 PACKING: 25KG/DRUM; APPLICATION:Anti-Bacterials -
Product Fluorobenzene
CAS: 462-06-6; Packing: 200KG/Drum; Application:It can be used for Pharmaceutical Intermediate -
Product Gamithromycin
CAS:145435-72-9 PACKING: 25KG/DRUM; APPLICATION:Anti-Bacterials -
Product Gamma Oryzanol
Standard: 99.0%; Packing:25KG/Drum; Application:Food Additives & Nutritional Ingredients & Cosmetic Additives -
Product Gemfibrozil
CAS: 247-280-2; Packing: 25KG/Drum; Application: Gemfibrozil is used with diet changes (restriction of cholesterol and fat intake) to reduce the amount of cholesterol and certain fatty substances in your blood. -
Product Glycine
CAS: 56-40-6 Packing: 25kg/bag Application: Glycine is used for treating schizophrenia, stroke, benign prostatic hyperplasia (BPH), and some rare inherited metabolic disorders. It is also used to protect kidneys from the harmful side effects of certain drugs used after organ transplantation as well as th... -
Product Hydrolyzed Fish Collagen
Standard: Food Grade/Cosmetic Grade Packing:20KG/Carton Application: Food Additives & Nutritional Ingredients & Cosmetic Additives -
Product Istretinoin
CAS:4759-48-2 Packing:1KG/BAG,5KG/BAG,25KG/DRUM Application:It is used to treat cystic acne. -
Product Ivermectin
CAS:70288-86-7 PACKING: 25KG/DRUM; APPLICATION:Anti-Endoparasites -
Product Latanoprost
CAS: 130209-82-4; Packing: 5G/Bottle; Application:It can be used to lower intraocular pressure -
Product LCZ696(SACUBITRIL+VALSARTAN)
CAS: 936623-90-4; Packing: 1KG/Tin; Application:LCZ696 (sacubitril/Valsartan) is a combination drug for use in heart failure developed by Novartis. It consists of valsartan and sacubitril, in a 1:1 mixture by molecule count. -
Product Ledipasvir
CAS: 1256388-51-8; Packing: 20KG/Drum; Application: Ledipasvir is most commonly used in combination with sofosbuvir for treatment in chronic hepatitis C genotype 1 patients. This drug has been tested and shown efficacy in treatment-naive and treatment experienced patients.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance